Aranz Medical Newsletter (569 KB)
In this edition of our newsletter, we look at a very painful skin condition - Epidermolysis Bullosa (EB) - which causes the skin to be fragile and blister. Silhouette has been and continues to be used by a number of Clinical Research organizations who are endeavoring to find better treatments for the people who live with this incurable condition. Read more about EB in the attachment.
I am thrilled to be able to announce that the new Silhouette suite of products will be available to ship this December. Our new range of wound imaging and documentation products give wound care practitioners in different care settings the ability to choose a device and the functionality that best suits their wound assessment and documentation needs.
The new products in our suite include:
- SilhouetteLite - for wound imaging and simple notes using Apple iPads and iPhones.
- SilhouetteLite+ - for wound imaging, 2D non-contact measurements, and more detailed notes using Apple iPads and iPhones.
- Wireless SilhouetteStar2 Camera - for fully featured wound imaging, 3D measuring, and documentation.
- New SilhouetteCentral Software - for web-based access to a centralized database of all the data collected from these devices.
Learn more about the new Silhouette suite of products in the attachment.
If your organization is interested in joining our Early Access Program to trial these products, please contact me directly.
Lakewood-Amedex Inc., a leading developer of anti-infective pharmaceuticals, is utilizing Silhouette in their study of a topically applied Bisphosphocin Nu-3 antimicrobial, for patients with infected diabetic foot ulcers (DFU). Read more.
We recently visited and spoke with a number of the staff at Parkview Medical Center in Pueblo, Colorado who have been using Silhouette in both their inpatient and outpatient clinics for over a year now. To hear what they had to see please see the attachment.
As always, if you have any questions or comments, please let me know.
T: +64 3 374 6120